切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2025, Vol. 21 ›› Issue (06) : 605 -610. doi: 10.3877/cma.j.issn.1673-5250.2025.06.001

标准·方案·指南

《老年卵巢癌规范化手术治疗中国专家共识(2024年版)》解读
张琳1,2, 张师前2,()   
  1. 1山东大学齐鲁医学院,济南 250012
    2山东大学齐鲁医院妇产科,济南 250012
  • 收稿日期:2025-05-31 修回日期:2025-08-20 出版日期:2025-12-01
  • 通信作者: 张师前

Interpretation of Chinese Expert Consensus on Standardized Surgical Treatment for Ovarian Cancer in Elderly Patients (2024 Edition)

Lin Zhang1,2, Shiqian Zhang2,()   

  1. 1Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong Province, China
    2Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan 250012, Shandong Province, China
  • Received:2025-05-31 Revised:2025-08-20 Published:2025-12-01
  • Corresponding author: Shiqian Zhang
  • Supported by:
    Research Project of 2022 Major Scientific Problems and Medical Technology Problems of China Medical Education Association(2022KTM024)
引用本文:

张琳, 张师前. 《老年卵巢癌规范化手术治疗中国专家共识(2024年版)》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(06): 605-610.

Lin Zhang, Shiqian Zhang. Interpretation of Chinese Expert Consensus on Standardized Surgical Treatment for Ovarian Cancer in Elderly Patients (2024 Edition)[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(06): 605-610.

《老年卵巢癌规范化手术治疗中国专家共识(2024年版)》(以下简称为《本共识》)提出,通过综合评估老年卵巢癌患者功能状态及肿瘤可切除性,强调术前调整衰弱与共病状况,术中优化麻醉策略与手术协作,术后实施加速康复(ERAS)、营养支持及并发症预防方案,可以降低围术期风险,优化手术决策。《本共识》将老年卵巢癌患者定义为≥65岁的卵巢癌患者。《本共识》为老年卵巢癌患者的规范化治疗提供了科学依据与实践指南。笔者拟就《本共识》进行解读,旨在推动临床对老年卵巢癌患者的规范化手术治疗。

Chinese Expert Consensus on Standardized Surgical Treatment for Ovarian Cancer in Elderly Patients (2024 Edition)(here after referred to as "the Consensus") advocates for optimized surgical decision-making by assessing patients′ functional status and tumor resectability. It emphasizes preoperative management of frailty and comorbidities, intraoperative optimization of anesthesia strategies and surgical collaboration, and postoperative implementation of enhanced recovery after surgery (ERAS) protocols, nutritional support, and complication prevention measures to reduce perioperative risks. The Consensus defines elderly ovarian cancer patients as those aged ≥65 years. By integrating evidence-based recommendations with practical guidance, the Consensus establishes a scientific framework for the standardized management of elderly ovarian cancer patients, offering critical insights to guide therapeutic practices. This article provides a comprehensive interpretation of the Consensus, aiming to promote standardized surgical treatment for elderly patients with ovarian cancer.

[1]
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263. DOI: 10.3322/caac.21834.
[2]
Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2017, National Cancer Institute[EB/OL]. (2020-04-15)[2025-01-12].

URL    
[3]
中国老年医学学会妇科分会. 老年卵巢癌规范化手术治疗中国专家共识(2024年版) [J]. 中华老年多器官疾病杂志2024, 23(11): 801-819. DOI: 10.11915/j.issn.1671-5403.2024.11.177.
[4]
Palaiologos K, Nikoloudaki Z, Adedipe T, et al. Ultra-radical surgery for advanced ovarian cancer: a retrospective cohort study in a tertiary referral cancer center in the UK [J]. Minerva Obstet Gynecol, 2024, 76(4): 319-326. DOI:10.23736/S2724-606X.22.05179-X.
[5]
Joueidi Y, Dion L, Bendifallah S, et al. Management and survival of elderly and very elderly patients with ovarian cancer: an age-stratified study of 1 123 women from the Francogyn Group [J]. J Clin Med, 2020, 9(5): 1451. DOI: 10.3390/jcm9051451.
[6]
Gaillard S, Lacchetti C, Armstrong DK, et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update [J]. J Clin Oncol, 2025, 43(7): 868-891. DOI: 10.1200/jco-24-02589.
[7]
Chase DM, Mahajan A, Scott DA, et al. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a Meta-analysis [J]. BMC Womens Health, 2024, 24(1): 179. DOI: 10.1186/s12905-024-02977-5.
[8]
Shahrokni A, Tin A, Alexander K, et al. Development and evaluation of a new frailty index for older surgical patients with cancer [J]. JAMA Network Open, 2019, 2(5): e193545. DOI: 10.1001/jamanetworkopen.2019.3545.
[9]
Horiuchi K, Kuno T, Takagi H, et al. Predictive value of the G8 screening tool for postoperative complications in older adults undergoing cancer surgery: a systematic review and Meta-analysis [J]. J Geriatr Oncol, 2024, 15(3): 101656. DOI: 10.1016/j.jgo.2023.101656.
[10]
Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer [J]. Gynecol Oncol, 2014, 134(3): 455-461. DOI: 10.1016/j.ygyno.2014.07.002.
[11]
Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study [J]. Ann Surg Oncol, 2006, 13(8): 1156-1161. DOI: 10.1245/aso.2006.08.021.
[12]
Shi T, Zhu J, Feng Y, et al. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial [J]. Lancet Oncol, 2021, 22(4): 439-449. DOI: 10.1016/s1470-2045(21)00006-1.
[13]
Arends J, Bodoky G, Bozzetti F, et al. ESPEN guidelines on enteral nutrition: non-surgical oncology [J]. Clin Nutr, 2006, 25(2): 245-259. DOI: 10.1016/j.clnu.2006.01.020.
[14]
Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer [J]. Eur J Clin Nutr, 2002, 56(8): 779-785. DOI: 10.1038/sj.ejcn.1601412.
[15]
Kuzma T, Glaze S, Duan Q, et al. Preoperative hypoalbuminemia is associated with increased mortality in patients undergoing surgery for gynaecologic malignancy - a retrospective cohort study [J]. J Obstet Gynaecol Can, 2023, 45(6): 395-401. DOI: 10.1016/j.jogc.2023.03.100.
[16]
Wobith M, Hill A, Fischer M, et al. Nutritional prehabilitation in patients undergoing abdominal surgery:a narrative review [J]. Nutrients, 2024, 16(14): 2235. DOI: 10.3390/nu16142235.
[17]
Messina A, Robba C, Calabrò L, et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a Meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery [J]. Crit Care, 2021, 25(1): 43. DOI: 10.1186/s13054-021-03464-1.
[18]
Sauro KM, Smith C, Ibadin S, et al. Enhanced recovery after surgery guidelines and hospital length of stay, readmission, complications, and mortality [J]. JAMA Netw Open, 2024, 7(6): e2417310. DOI: 10.1001/jamanetworkopen.2024.17310.
[1] 田湘英, 缪华章, 徐玲, 涂艳萍, 张婕, 相光华, 赵贤哲, 尚宁. 卵巢颗粒细胞瘤与卵泡膜-纤维瘤组的超声特征及临床病理分析[J/OL]. 中华医学超声杂志(电子版), 2025, 22(04): 311-320.
[2] 卢菊, 赵胜, 范建华, 高艳多. 探讨IOTA、GI-RADS及O-RADS在附件肿瘤良恶性鉴别诊断中的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 484-490.
[3] 阎昊铮, 黄玥, 李征宇. 晚期上皮性卵巢癌手术复杂度与术后肿瘤残留病灶及并发症的相关性分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(04): 403-410.
[4] 何玥, 吴玉梅. 《老年宫颈癌规范化诊疗中国专家共识(2024年版)》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(04): 395-402.
[5] 赵颖, 尹晓宇, 步华磊. 卵巢癌的分子诊疗临床应用现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(04): 380-385.
[6] 曹司雨, 赵成钰, 李金科. 交界性和恶性卵巢肿瘤育龄患者保留生育功能的相关思考[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(03): 271-277.
[7] 王秋毅, 黄薇. 妇科恶性肿瘤年轻患者生育力保存的临床实践与挑战[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(03): 266-270.
[8] 杨姝瑞, 罗灿, 牛晓宇. 《使用合成网片的盆腔器官脱垂手术后并发症的诊断和管理:法国临床实践指南》要点解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(03): 257-265.
[9] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[10] 章宇潇, 杨凡, 毛萌. 《生长减缓婴幼儿的追赶性生长:指导普通临床医师的专家共识(2023版)》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 361-366.
[11] 罗成燕, 袁琳, 周树林, 姜旖, 陈婷, 王聪, 程文俊. 腹腔镜下间歇性肿瘤细胞减灭术在晚期卵巢癌的临床应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 339-345.
[12] 刘庭秀, 刘新敏, 刘莹, 隋娟, 武宇, 赵瑜敬, 毕红, 孙雪梅, 范秀华. 腹壁整形术后腹腔镜新脐入路治疗卵巢肿物的安全性探讨[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(03): 189-192.
[13] 林卓涛, 杨科力, 王辉. 腹膜假黏液瘤肿瘤细胞减灭手术策略[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(06): 481-490.
[14] 张颖, 赵鑫, 陈佳梅, 李雁. 术前化疗对CRS+HIPEC 治疗腹膜假黏液瘤预后影响的meta 分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 826-835.
[15] 杜凤英, 刘一凡. 老年住院患者导尿管相关尿路感染的流行病学特征和危险因素分析[J/OL]. 中华老年病研究电子杂志, 2024, 11(04): 26-30.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?